» Authors » Claudio Salaris

Claudio Salaris

Explore the profile of Claudio Salaris including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 105
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bellato M, Cappellato M, Longhin F, Del Vecchio C, Brancaccio G, Cattelan A, et al.
Sci Rep . 2023 Oct; 13(1):16867. PMID: 37803040
The outbreak of Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, forced us to face a pandemic with unprecedented social, economic, and public health consequences. Several nations have launched campaigns to...
2.
Salvati M, Salaris C, Monteil V, Del Vecchio C, Palu G, Parolin C, et al.
J Virol . 2021 Oct; 95(24):e0163821. PMID: 34613808
Crimean-Congo hemorrhagic fever (CCHF) is a severe disease of humans caused by CCHF virus (CCHFV), a biosafety level (BSL)-4 pathogen. Ticks of the genus are the viral reservoir, and they...
3.
Salaris C, Scarpa M, Elli M, Bertolini A, Guglielmetti S, Pregliasco F, et al.
Gut Microbes . 2021 Aug; 13(1):1961970. PMID: 34365895
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the ongoing global pandemic of coronavirus disease 2019 (COVID-19), which primarily manifests with respiratory distress and may also lead...
4.
Cegolon L, Mirandola M, Salaris C, Salvati M, Mastrangelo G, Salata C
Pathogens . 2021 Mar; 10(2). PMID: 33669635
SARS-CoV-2 replicates efficiently in the upper airways during the prodromal stage, resulting in environmental viral shedding from patients with active COVID-19 as well as from asymptomatic individuals. There is a...
5.
Salaris C, Scarpa M, Elli M, Bertolini A, Guglielmetti S, Pregliasco F, et al.
Nutrients . 2021 Jan; 13(2). PMID: 33498631
SARS-CoV-2 is a newly emerging virus that currently lacks curative treatments. Lactoferrin (LF) is a naturally occurring non-toxic glycoprotein with broad-spectrum antiviral, immunomodulatory and anti-inflammatory effects. In this study, we...